Skip to content

Molecular basis of lymphatic dysplasia in children

Molecular basis of lymphatic dysplasia in children - DNALymph

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38818
Enrollment
105
Registered
2013-08-30
Start date
2013-09-01
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lymphedema

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients * Diagnosed with lymphatic dysplasia in infancy or early childhood * Parents / caregivers of patients able to read and understand the written information Parents * Parents of patients with lymphatic dysplasia as a child * Able to read and understand the written information

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Detection of further gene(s) causing lymphatic dysplasia in children.

Secondary

MeasureTime frame
- Understanding the molecular and cellular mechanisms leading to the various manifestations of lymphatic dysplasia in children. - Increase of our understanding of lymph vessel formation in man

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)